Report error Found 27 Enz. Inhib. hit(s) with all data for entry = 13289
Affinity DataIC50: 0.360nMAssay Description:Inhibitory activities of the compound of the present application on three kinases TRKa, TRKA(G595R) and TRKC(G623R) were measured.2. Experimental Mat...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.390nMAssay Description:Inhibitory activities of the compound of the present application on three kinases TRKa, TRKA(G595R) and TRKC(G623R) were measured.2. Experimental Mat...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.420nMAssay Description:Inhibitory activities of the compound of the present application on three kinases TRKa, TRKA(G595R) and TRKC(G623R) were measured.2. Experimental Mat...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.430nMAssay Description:Inhibitory activities of the compound of the present application on three kinases TRKa, TRKA(G595R) and TRKC(G623R) were measured.2. Experimental Mat...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.470nMAssay Description:Inhibitory activities of the compound of the present application on three kinases TRKa, TRKA(G595R) and TRKC(G623R) were measured.2. Experimental Mat...More data for this Ligand-Target Pair
Affinity DataIC50: 0.520nMAssay Description:Inhibitory activities of the compound of the present application on three kinases TRKa, TRKA(G595R) and TRKC(G623R) were measured.2. Experimental Mat...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.620nMAssay Description:Inhibitory activities of the compound of the present application on three kinases TRKa, TRKA(G595R) and TRKC(G623R) were measured.2. Experimental Mat...More data for this Ligand-Target Pair
Ligand Info
TargetHigh affinity nerve growth factor receptor [G595R](Human)
Scinnohub Pharmaceutical Co.
US Patent
Scinnohub Pharmaceutical Co.
US Patent
Affinity DataIC50: 0.720nMAssay Description:Inhibitory activities of the compound of the present application on three kinases TRKa, TRKA(G595R) and TRKC(G623R) were measured.2. Experimental Mat...More data for this Ligand-Target Pair
Ligand Info
TargetHigh affinity nerve growth factor receptor [G595R](Human)
Scinnohub Pharmaceutical Co.
US Patent
Scinnohub Pharmaceutical Co.
US Patent
Affinity DataIC50: 0.890nMAssay Description:Inhibitory activities of the compound of the present application on three kinases TRKa, TRKA(G595R) and TRKC(G623R) were measured.2. Experimental Mat...More data for this Ligand-Target Pair
Ligand Info
TargetHigh affinity nerve growth factor receptor [G595R](Human)
Scinnohub Pharmaceutical Co.
US Patent
Scinnohub Pharmaceutical Co.
US Patent
Affinity DataIC50: 0.970nMAssay Description:Inhibitory activities of the compound of the present application on three kinases TRKa, TRKA(G595R) and TRKC(G623R) were measured.2. Experimental Mat...More data for this Ligand-Target Pair
Ligand Info
TargetHigh affinity nerve growth factor receptor [G595R](Human)
Scinnohub Pharmaceutical Co.
US Patent
Scinnohub Pharmaceutical Co.
US Patent
Affinity DataIC50: 1.20nMAssay Description:Inhibitory activities of the compound of the present application on three kinases TRKa, TRKA(G595R) and TRKC(G623R) were measured.2. Experimental Mat...More data for this Ligand-Target Pair
Ligand Info
TargetNT-3 growth factor receptor [G623R](Homo sapiens (Human))
Scinnohub Pharmaceutical Co.
US Patent
Scinnohub Pharmaceutical Co.
US Patent
Affinity DataIC50: 1.40nMAssay Description:Inhibitory activities of the compound of the present application on three kinases TRKa, TRKA(G595R) and TRKC(G623R) were measured.2. Experimental Mat...More data for this Ligand-Target Pair
Ligand Info
TargetNT-3 growth factor receptor [G623R](Homo sapiens (Human))
Scinnohub Pharmaceutical Co.
US Patent
Scinnohub Pharmaceutical Co.
US Patent
Affinity DataIC50: 1.5nMAssay Description:Inhibitory activities of the compound of the present application on three kinases TRKa, TRKA(G595R) and TRKC(G623R) were measured.2. Experimental Mat...More data for this Ligand-Target Pair
Ligand Info
TargetHigh affinity nerve growth factor receptor [G595R](Human)
Scinnohub Pharmaceutical Co.
US Patent
Scinnohub Pharmaceutical Co.
US Patent
Affinity DataIC50: 1.60nMAssay Description:Inhibitory activities of the compound of the present application on three kinases TRKa, TRKA(G595R) and TRKC(G623R) were measured.2. Experimental Mat...More data for this Ligand-Target Pair
TargetNT-3 growth factor receptor [G623R](Homo sapiens (Human))
Scinnohub Pharmaceutical Co.
US Patent
Scinnohub Pharmaceutical Co.
US Patent
Affinity DataIC50: 1.70nMAssay Description:Inhibitory activities of the compound of the present application on three kinases TRKa, TRKA(G595R) and TRKC(G623R) were measured.2. Experimental Mat...More data for this Ligand-Target Pair
Ligand Info
TargetNT-3 growth factor receptor [G623R](Homo sapiens (Human))
Scinnohub Pharmaceutical Co.
US Patent
Scinnohub Pharmaceutical Co.
US Patent
Affinity DataIC50: 1.80nMAssay Description:Inhibitory activities of the compound of the present application on three kinases TRKa, TRKA(G595R) and TRKC(G623R) were measured.2. Experimental Mat...More data for this Ligand-Target Pair
Ligand Info
TargetHigh affinity nerve growth factor receptor [G595R](Human)
Scinnohub Pharmaceutical Co.
US Patent
Scinnohub Pharmaceutical Co.
US Patent
Affinity DataIC50: 2.5nMAssay Description:Inhibitory activities of the compound of the present application on three kinases TRKa, TRKA(G595R) and TRKC(G623R) were measured.2. Experimental Mat...More data for this Ligand-Target Pair
Ligand Info
TargetNT-3 growth factor receptor [G623R](Homo sapiens (Human))
Scinnohub Pharmaceutical Co.
US Patent
Scinnohub Pharmaceutical Co.
US Patent
Affinity DataIC50: 2.5nMAssay Description:Inhibitory activities of the compound of the present application on three kinases TRKa, TRKA(G595R) and TRKC(G623R) were measured.2. Experimental Mat...More data for this Ligand-Target Pair
TargetHigh affinity nerve growth factor receptor [G595R](Human)
Scinnohub Pharmaceutical Co.
US Patent
Scinnohub Pharmaceutical Co.
US Patent
Affinity DataIC50: 2.90nMAssay Description:Inhibitory activities of the compound of the present application on three kinases TRKa, TRKA(G595R) and TRKC(G623R) were measured.2. Experimental Mat...More data for this Ligand-Target Pair
Ligand Info
TargetNT-3 growth factor receptor [G623R](Homo sapiens (Human))
Scinnohub Pharmaceutical Co.
US Patent
Scinnohub Pharmaceutical Co.
US Patent
Affinity DataIC50: 3.70nMAssay Description:Inhibitory activities of the compound of the present application on three kinases TRKa, TRKA(G595R) and TRKC(G623R) were measured.2. Experimental Mat...More data for this Ligand-Target Pair
Ligand Info
TargetNT-3 growth factor receptor [G623R](Homo sapiens (Human))
Scinnohub Pharmaceutical Co.
US Patent
Scinnohub Pharmaceutical Co.
US Patent
Affinity DataIC50: 8.20nMAssay Description:Inhibitory activities of the compound of the present application on three kinases TRKa, TRKA(G595R) and TRKC(G623R) were measured.2. Experimental Mat...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 127nMAssay Description:Inhibitory activities of the compound of the present application on three kinases TRKa, TRKA(G595R) and TRKC(G623R) were measured.2. Experimental Mat...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 320nMAssay Description:Inhibitory activities of the compound of the present application on three kinases TRKa, TRKA(G595R) and TRKC(G623R) were measured.2. Experimental Mat...More data for this Ligand-Target Pair
Ligand Info
TargetHigh affinity nerve growth factor receptor [G595R](Human)
Scinnohub Pharmaceutical Co.
US Patent
Scinnohub Pharmaceutical Co.
US Patent
Affinity DataIC50: 561nMAssay Description:Inhibitory activities of the compound of the present application on three kinases TRKa, TRKA(G595R) and TRKC(G623R) were measured.2. Experimental Mat...More data for this Ligand-Target Pair
Ligand Info
TargetHigh affinity nerve growth factor receptor [G595R](Human)
Scinnohub Pharmaceutical Co.
US Patent
Scinnohub Pharmaceutical Co.
US Patent
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibitory activities of the compound of the present application on three kinases TRKa, TRKA(G595R) and TRKC(G623R) were measured.2. Experimental Mat...More data for this Ligand-Target Pair
Ligand Info
TargetNT-3 growth factor receptor [G623R](Homo sapiens (Human))
Scinnohub Pharmaceutical Co.
US Patent
Scinnohub Pharmaceutical Co.
US Patent
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibitory activities of the compound of the present application on three kinases TRKa, TRKA(G595R) and TRKC(G623R) were measured.2. Experimental Mat...More data for this Ligand-Target Pair
Ligand Info
TargetNT-3 growth factor receptor [G623R](Homo sapiens (Human))
Scinnohub Pharmaceutical Co.
US Patent
Scinnohub Pharmaceutical Co.
US Patent
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibitory activities of the compound of the present application on three kinases TRKa, TRKA(G595R) and TRKC(G623R) were measured.2. Experimental Mat...More data for this Ligand-Target Pair
Ligand Info
